BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33941198)

  • 1. Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients.
    Sun G; Sun K; Shen C
    World J Surg Oncol; 2021 Apr; 19(1):137. PubMed ID: 33941198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
    Wang W; Wang L; Xie X; Yan Y; Li Y; Lu Q
    BMC Cancer; 2021 Jan; 21(1):6. PubMed ID: 33402113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic Analysis to Identify a Multi-mRNA Signature for the Prediction of Metastasis in Hepatocellular Carcinoma.
    Liu L; Wang B; Han Q; Zhen C; Li J; Qu X; Wang F; Kong X; Zheng L
    DNA Cell Biol; 2020 Nov; 39(11):2028-2039. PubMed ID: 33147069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
    BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma.
    Wang X; Qiao J; Wang R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
    Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
    BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
    Chen W; Tang D; Ou M; Dai Y
    DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Xie WX; Zhang CY; Xu JW
    J Cell Physiol; 2020 Feb; 235(2):1624-1636. PubMed ID: 31309563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
    Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
    Liu R; Wang G; Zhang C; Bai D
    World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y
    Life Sci; 2020 Nov; 260():118396. PubMed ID: 32918973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.